Home Faculty and Staff Hospitals and Offices Education / Fellowships Make an Appointment
Keck School of Medicine of USC - University of Southern California
Department of Surgery
Department links
Home Physicians Locations Education Society of Graduate Surgeons Contact Us Divisions and Institutes
CardioVascular Thoracic Institute
image map
Areas of Expertise Diseases & Treatments Clinical Trials Research News & Articles Videos Web Links
Patient Guides & Programs Visitor's Guide Forms & Downloads About CVTI Make a Gift Contact Us

Mesenchymal Stem Cells in Autograft Fibrosis

Chronic rejection is a serious complication of organ transplantation, even in the presence of immunosuppression. Chronic rejection typically results in fibrosis of the graft--the laying down of excess extra cellular matrix until the organ becomes dysfunctional. Despite the widely appreciated magnitude of the problem and the numerous research efforts to control it, effective therapies to control allograft fibrosis are lacking. Fibroblasts are the sole cell type that forms the scar tissue that eventually leads to the dysfunction of the transplanted organs. The mechanisms that control the recruitment, differentiation, and proliferation of intragraft fibroblasts are poorly understood. Recent data have suggested that proliferating intragraft fibroblasts are derived from transplant recipients. New findings indicate that mesenchymal stem cells (MSC) play an important role in the development of allograft fibrosis. The long-term goals of the research program are to apply genetic and cellular therapies for chronic rejection of solid organ transplants.


Share this page:
Call us for an Appointment at (323) 442-5849
In This Section
Department of Surgery Home Divisions Physicians Locations Contact Us Education Society of Graduate Surgeons Keck School of Medicine of USC University of Southern California